======= GATAD2B ======= == Gene Information == * **Official Symbol**: GATAD2B * **Official Name**: GATA zinc finger domain containing 2B * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=57459|57459]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8WXI9|Q8WXI9]] * **Interactions**: [[https://thebiogrid.org/search.php?search=GATAD2B&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20GATAD2B|Open PubMed]] * **OMIM**: [[https://omim.org/entry/614998|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a zinc finger protein transcriptional repressor. The encoded protein is part of the methyl-CpG-binding protein-1 complex, which represses gene expression by deacetylating methylated nucleosomes. Mutations in this gene are linked to intellectual disability and dysmorphic features associated with cognitive disability. [provided by RefSeq, Jun 2016]. * **UniProt Summary**: Transcriptional repressor. Enhances MBD2-mediated repression. Efficient repression requires the presence of GATAD2A. Targets MBD3 to discrete loci in the nucleus. May play a role in synapse development. {ECO:0000269|PubMed:12183469, ECO:0000269|PubMed:16415179}. |GATA| |NuRD complex| |nucleosomal DNA binding| |ATP-dependent chromatin remodeling| |RNA polymerase II distal enhancer sequence-specific DNA binding| |chromatin remodeling| |nuclear chromatin| |nuclear speck| |RNA polymerase II proximal promoter sequence-specific DNA binding| |protein-containing complex| |chromatin organization| |zinc ion binding| |negative regulation of transcription by RNA polymerase II| |chromosome organization| |negative regulation of transcription, DNA-templated| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |DNA-binding transcription factor activity, RNA polymerase II-specific| |negative regulation of gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|-2.22| |[[:results:exp101|Nicotinamide 1000μM R03 exp101]]|-2.17| |[[:results:exp419|Tunicamycin 0.04 to 0.075μM on day4 R07 exp419]]|-1.82| |[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|-1.74| |[[:results:exp331|A-769662 20μM R07 exp331]]|-1.73| |[[:results:exp488|Hippuristanol 0.12μM R08 exp488]]|1.81| |[[:results:exp238|Parthenolide 2.5μM R05 exp238]]|1.87| |[[:results:exp531|THZ1 0.06μM R08 exp531]]|1.94| |[[:results:exp326|CCT251545 20μM R07 exp326]]|1.95| |[[:results:exp489|Hippuristanol 0.12μM R08 exp489 no dilution day6]]|2.04| |[[:results:exp439|QNZ 0.01μM R08 exp439]]|2.15| |[[:results:exp445|∆-9-Tetrahydrocannabinol 30μM R08 exp445]]|2.29| |[[:results:exp466|Cannabidiol 20μM R08 exp466]]|2.64| ^Gene^Correlation^ |[[:human genes:m:mbd3|MBD3]]|0.408| Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 14921 * **Expression level (log2 read counts)**: 6.61 {{:chemogenomics:nalm6 dist.png?nolink |}}